Patent · US Active

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

US10906928B2 · kind B2 · utility

2Cited by
136References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2019
Grant dateFeb 2, 2021
Priority date—
Expiry dateNov 18, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.